A frail patient facing multiple overlapping symptoms often ends up on complex, high-risk medication combinations. But what if one drug could replace many?

This video breaks down how olanzapine—originally designed for psychiatric use—works as a powerful multi-pathway antagonist to control nausea, anxiety, insomnia, and delirium simultaneously. By targeting dopamine and serotonin pathways, and acting directly on the chemoreceptor trigger zone, it offers a smarter, simplified approach in palliative care.

When used carefully at low doses, it reduces polypharmacy, improves comfort, and transforms how complex symptoms are managed in serious illness.